Pharmapedia

SPERMICIDAL CONDOM AND RISK OF URINARY TRACT INFECTION IN FEMALE

ABOUT AUHTOR
Priyatama V. Powar
Pharmaceutics Department
Dr. D. Y. Patil College of Pharmacy,
Akurdi, Pune-44
priyatama.powar@gmail.com

Urinary Tract Infections are common health problems in clinical practice in all age groups both male and female cause by bacteria that affects urinary system. Occurrence and frequency of Urinary Tract Infection is higher in female as compare to male because of mainly following reasons


HOW DIGITALIZATION CAN BE UTILIZED FOR BETTER MARKETING & SALES IN PHARMACEUTICALS

ABOUT AUHTOR
Rajesh Vagh
PharmaTutor Edu Labs
Surat, Gujarat, India

So far, medical representatives are assets for pharma sales but need of time and competitions are asking for variant ways to promote their products. Patient portals, apps and online communities should be developed with more intensity and utilize technologies to improve customer experience.


GATEWAYS TO DRUG ABUSE: A BRIEF REPORT ON PUNJAB & HARYANA

ABOUT AUHTORS
Piyush Tripathi*,  Abhishek Arora
GMSCL,
GUJARAT(INDIA)
*piyushtripathi1992@rediffmail.com

Drug addiction is a serious problem in one country that is known for its culture, traditions & social values all over the world. The country where people commit suicide either because of love affairs or due to drug addiction related issues. Undoubtedly, this writing is talking about India.


APPEARING IN B.PHARMACY EXAMINATION ( SESSIONAL/ SEMESTER END/ YEAR END FINAL EXAMINATION) : AN ART OR SCIENCE?

{ DOWNLOAD AS PDF }

ABOUT AUHTORS
BALVINDER SINGH1*, PAWAN JALWAL 1, VIKASH KUMAR RUHIL 2, NEHA MINOCHA1
1.Department of Pharmaceutical Sciences & Research, Baba Mastnath University, Asthal Bohar, Rohtak, Haryana, India
2. P.D.M. College of Pharmacy, Bahadurgarh, Haryana, India
balvindersinghpharmaco@gmail.com

ABSTRACT
B.Pharmacy course is one of the leading professional courses in India. Two types of examinations are prevalent in B.Pharmacy course. One is the sessional examinations for internal evaluation. Second is the semester end/year end examination. Each examination has its own importance. The student should be well prepared for appearing in the examination. Appearing in the B.Pharm. Examination is not only merely science but it requires amalgamation of science and art.


CHALLENGES ENCOUNTERED BY PHARMA PROJECT MANAGER

ABOUT AUHTOR
Purva Gupta.
IIHMR, New Delhi.
purvagupta456@gmail.com

New Domain: This problem arises when organisation has not handled similar project earlier and stake holders have no prior experience on the project.

New Technology / Challenging Technology: Selected Project involves use of new technology or new equipment or specially trained staff may pose delay in completion of task, thereby project.


AN APPROVAL TO MANUFACTURE AND SALE THE COPY OF INNOVATOR PRODUCT IN THE US MARKET

{ DOWNLOAD AS PDF }

ABOUT AUHTORS
MUNISH THAKUR*,  Dr. ANUPAMA SETIA, Ms. NEETU.
DEPARTMENT OF PHARMACEUTICAL MANAGEMENT &
 DRUG REGULATORY AFFAIRS,
JCDM COLLEGE OF PHARMACY,
SIRSA-HARYANA (INDIA).
munish.thakur98@gmail.com

ABSTRACT
The drug designated for production has to be manufactured in compliance with Current Good Manufacturing Practices (cGMP) following USFDA requirements, EU Directive or International Conference on Harmonization (ICH) Guidelines or Regulatory Authority of respective country. Regulatory authorities bear the responsibility to conduct inspections on pharmaceutical manufacturing plants to ensure they follows cGMP guidelines so that the drug manufactured is safe and effective. A quality system has to be set up such that the drug is manufactured in accordance with approved procedures. A drug is not permitted for sale until the marketing application for the new drug has been reviewed and approved by regulatory authorities. Extensive dossiers are provided to the authorities to demonstrate the safety, potency, efficacy and purity of the drug. After the drug has been approved and marketed, there is continuous monitoring of the safety and performance of the drug to ensure that it is prescribed correctly and adverse events (side effects) are investigated. The United States Food and Drugs Administration (FDA) has one of the most comprehensive and transparent regulatory systems in the world. In US Common Technical Document (CTD) format and most recently its electronic version-the electronic Common Technical Document (eCTD) format is used for submission of dossiers. Inclusion of a paragraph IV certification permits the Applicant to file its ANDA 4 years after the approval of a new chemical entity that is 1 year before the actual expiry of the 5 years exclusivity. In case patent exists that claims the drug, drug product, or method of use, the applicant is requested to file a patent certification with regards to the patent status. The different types of patent certifications are discussed. This project work elucidates US FDA’s previous interpretations of the statute regarding 180 days exclusivity and latest amendments in the current guidance. Information considered helpful in the compilation of different CTD modules 1, 2, 3, and 5 is discussed. Electronic submission in eCTD format is outlined.


Nobel to Artimsisinin discoverer will surely encourage research in natural products

Amit Gangwal
MPharm., PhD.,
gangwal.amit@gmail.com

This has been made possible by years of honest research in Ayurvedic formulae and therefore people are getting results. This is not a small success, looking at the no of years, Patanjali has been in market and it’s whopping turnover.

The Nobel Prize in Physiology or Medicine has been awarded 106 times to 210 Nobel Laureates between 1901 and 2015, as per the information depicted on nobelprize.org/nobel_prizes/medicine/ laureates/. It further reads-The Nobel Prize in Physiology or Medicine 2015 was divided, one half jointly to William C. Campbell and Satoshi Ōmura "for their discoveries concerning a novel therapy against infections caused by roundworm parasites" and the other half to Youyou Tu "for her discoveries concerning a novel therapy against Malaria".


Challenges of Packaging and Labeling in the Pharma Industry

A recent study carried out by Pharma IQ has shed some light on some very common problems pharmaceutical companies face in the field of Packaging and Labeling. Companies already know their internal challenges, but are often unaware of the global trend of recurring issues and solutions to overcoming them. This is because the strict rules and regulations of packaging quality control in pharma, are not only strict, but also vary across different parts of the world.


Are pharmacists and colleges ready for a big change?

ABOUT AUHTOR
Amit Gangwal
gangwal.amit@gmail.com

Perhaps for the first time in the history of pharmaceutical sciences (from view point of academicians, graduating pharmacy students and other stake holders) things are appearing (not confirmed) vibrant and auguring well looking at future. This has been made possible by the recent notification in Gazette of India. Though I could not construe the meaning what is being interpreted by many on social platforms and few newspapers have also published the same. The newspapers’ shots I am sharing here for better understanding of readers and other stake holders. This interpretation of certain people on social media has also been opposed by Indian Medical Association (IMA). IMA said the notification by government does not empowers or entitles registered pharmacists to practice as qualified MBBS.


Pages